Clinical Epidemiology and Precision Diagnostics for a Regionwide Cohort of Bloodstream Infections

Simple item page
dc.contributor.advisorLewis, Ian
dc.contributor.authorMansuri, Alikhan
dc.contributor.committeememberGregson, Daniel
dc.contributor.committeememberPrenner, Elmar
dc.date2026-06
dc.date.accessioned2023-05-17T15:01:10Z
dc.date.available2023-05-17T15:01:10Z
dc.date.issued2023-05-08
dc.description.abstractBloodstream infections (BSIs) pose considerable morbidity for patients including progression to septic shock, a life-compromising disease with 30% mortality rate at 30 days from the onset of infection. During my MSc, I have advanced the idea of Precision Infection Management (PIM) as a novel treatment strategy that accounts for microbial virulence alongside host factors for improving mortality rates from BSIs. To lay the foundation for PIM, I conducted two investigations on a 14-year BSI cohort obtained from the Calgary Health Zone. My first objective was to systematically assess the impact of growing antimicrobial resistance on patient mortality trends. I uncovered increasing resistance rates across multiple first-line drugs, including E. coli resistance for ceftriaxone (binomial test p < 0.05). Despite this, E. coli mortality rates remained remarkably stable through the study period (linear model R2 = 0.2). While encouraging, 30-day mortality rates were worryingly high for some species, trending upwards of 30%, furthering a need for the PIM clinical strategy for reducing burden of disease. To address this, I identified microbial virulence factors that could be tested for in the diagnosis of BSIs. I leveraged a cohort of >600 E. faecium isolates and linked microbial proteomic profiles with patient 30-day mortality using Cox proportional hazard and log-rank tests. I identified arcB_1 expression as being significantly associated with 5035 days decreased survival through a 30-day window (adjusted log rank p = 0.0078). While preliminary, this finding is an exciting proof of principle for PIM and implicates virulence-directed therapy as a feasible and promising new treatment avenue that could reduce 30-day mortality.
dc.identifier.citationMansuri, A. (2023). Clinical epidemiology and precision diagnostics for a regionwide cohort of bloodstream infections (Master's thesis, University of Calgary, Calgary, Canada). Retrieved from https://prism.ucalgary.ca.
dc.identifier.urihttps://hdl.handle.net/1880/116542
dc.identifier.urihttps://dx.doi.org/10.11575/PRISM/dspace/41385
dc.language.isoen
dc.publisher.facultyGraduate Studies
dc.publisher.institutionUniversity of Calgary
dc.rightsUniversity of Calgary graduate students retain copyright ownership and moral rights for their thesis. You may use this material in any way that is permitted by the Copyright Act or through licensing that has been assigned to the document. For uses that are not allowable under copyright legislation or licensing, you are required to seek permission.
dc.subjectPrecision Medicine
dc.subjectBloodstream Infections
dc.subject.classificationEpidemiology
dc.subject.classificationEducation--Health
dc.titleClinical Epidemiology and Precision Diagnostics for a Regionwide Cohort of Bloodstream Infections
dc.typemaster thesis
thesis.degree.disciplineBiological Sciences
thesis.degree.grantorUniversity of Calgary
thesis.degree.nameMaster of Science (MSc)
ucalgary.thesis.accesssetbystudentI do not require a thesis withhold – my thesis will have open access and can be viewed and downloaded publicly as soon as possible.
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
ucalgary_2023_mansuri_alikhan.pdf
Size:
2.86 MB
Format:
Adobe Portable Document Format
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
2.62 KB
Format:
Item-specific license agreed upon to submission
Description:
Download
Collections
Open Theses and Dissertations